Many studies have confirmed the dysregulation of serine uptake or biosynthesis in tumour cells, as well as abnormal PHGDH expression, in different tumours, including lymphoma, multiple myeloma, glioma, hepatocellular carcinoma, melanoma, colon cancer, breast cancer, and others 32-38. This evidence concerns the gene PHGDH and plasma cell myeloma.